Turning Point Therapeutics Inc

NASDAQ:TPTX  
35.81
-2.99 (-7.71%)
Earnings Announcements

Turning Point Therapeutics Posts Quarterly Loss Per Share Of $1.34

Published: 11/09/2021 21:52 GMT
Turning Point Therapeutics Inc (TPTX) - Turning Point Therapeutics Reports Third-quarter Financial Results, Provides Operational Updates.
Qtrly Loss per Share $1.34.
Q3 Earnings per Share View $-1.27-- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.37

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.30

More details on our Analysts Page.